Both in Pharmaceuticals
CDT Equity vs Decoy Therapeutics
Over the past year CDT returned −100.0% and DCOY returned −78.0%; their daily moves had a correlation of -0.01.
CDT −100.0% DCOY −78.0%Growth of $1, one year, split-adjusted
| Metric | CDT | DCOY |
|---|---|---|
| Price | $1.49 | $2.04 |
| Market cap | $1.2M | $1.3M |
| Today | −96.86% | −11.90% |
| 1 month | −96.5% | −29.8% |
| 6 months | −99.9% | −69.9% |
| Year to date | −100.0% | — |
| 1 year | −100.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1042.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 1,165.8% | 133.4% |
| Short % of float | 34.8% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).